| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 695940 | Null | 0.0280810439814505 | 0.36153331 |
| NSC 726195 | 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one | 0.0280810439814505 | 0.22745773 |
| NSC 744622 | 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide | 0.0280810439814505 | 0.13396157 |
| NSC 752385 | Null | 0.0280810439814505 | 0.28458356 |
| NSC 81206 | Null | 0.0280810439814509 | 0.47161028 |
| NSC 115928 | Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) | 0.0303734648501639 | 0.41916533 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0303734648501639 | 0.3387673 |
| NSC 287459 | Cytarabine AY | 0.0303734648501639 | 0.43332393 |
| NSC 336053 | 1-Piperidinesulfonamide, N-(7-amino-2-naphthalenyl)- | 0.0303734648501639 | 0.24952728 |
| NSC 35580 | Null | 0.0303734648501639 | 0.38915761 |